Sign Up to like & get
recommendations!
1
Published in 2020 at "Biochemical and biophysical research communications"
DOI: 10.1016/j.bbrc.2020.11.002
Abstract: Modifying T cells to attack tumors using engineered chimeric receptors display powerful new therapeutic capabilities. Unfortunately, the effectiveness of therapeutic T cells is limited due to the inherent T cell responses: certain facets of endogenous…
read more here.
Keywords:
cxcl10 encoding;
anti tumor;
synnotch cells;
synnotch ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "ACS Nano"
DOI: 10.1021/acsnano.4c01597
Abstract: Programmed death-ligand 1 (PD-L1) is a promising target for cancer immunotherapy due to its ability to inhibit T cell activation; however, its expression on various noncancer cells may cause on-target off-tumor toxicity when designing PD-L1-targeting…
read more here.
Keywords:
synnotch;
pdbody;
tumor;
car ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "ACS sensors"
DOI: 10.1021/acssensors.4c01997
Abstract: Synthetic Notch (synNotch) receptors have enabled mammalian cells to sense extracellular ligands and respond by activating user-prescribed transcriptional programs. Based on the synNotch system, we describe a cell-based in vivo sensor for cancerous cell detection.…
read more here.
Keywords:
cancer;
synnotch;
cell;
synnotch programmed ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "ACS Synthetic Biology"
DOI: 10.1021/acssynbio.2c00247
Abstract: The Notch pathway converts receptor-ligand interactions at the cell surface into a transcriptional response in the receiver cell. In recent years, synthetic Notch systems (SynNotch) that respond to different inputs and transduce different transcriptional responses…
read more here.
Keywords:
synnotch;
ligand icd;
notch systems;
synthetic notch ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2025.1545270
Abstract: Cancer immunotherapy has been transformed by chimeric antigen receptor (CAR) T-cell treatment, which has shown groundbreaking results in hematological malignancies. However, its application in solid tumors remains a formidable challenge due to immune evasion, tumor…
read more here.
Keywords:
synnotch;
immunology;
car cell;
biology ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Current Issues in Molecular Biology"
DOI: 10.3390/cimb46040183
Abstract: Natural killer (NK) cells are crucial components of innate immunity, known for their potent tumor surveillance abilities. Chimeric antigen receptors (CARs) have shown promise in cancer targeting, but optimizing CAR designs for NK cell functionality…
read more here.
Keywords:
receptor;
synnotch;
killer cells;
natural killer ... See more keywords